BRIEF — Lakefront Announces Sale Of Preclinical Car — T Programs To Armed Cell Therapeutics

Oct 14 (Reuters) — Lakefront Biotherapeutics NV: Lakefront Announces Sale Of Preclinical Car-t Programs To Armed Cell Therapeutics Lakefront Biotherapeutics Nv: Armed Cell Therapeutics To Independently Advance Bought Cell Therapy Programs Lakefront Biotherapeutics Nv: Terms Of Deal Include Upfront Payment Of Eur 8 Million & Potential For Up To $230 Million In Milestone Payments Lakefront Biotherapeutics Nv: Intention To Wind Down Cell Therapy Activities After Review Of Strategic Alternatives Is Substantially Complete Source text:... Further company coverage: LKFT.AS (((Reuters.Briefs@thomsonreuters.com;));)